FDA issued a warning letter to CanaRx for illegally distributing drugs into the U.S. that have not been approved by the FDA for safety and effectiveness.
Read more: FDA warns CanaRx for selling unapproved, misbranded and unsafe imported drugs to unsuspecting Americans
Thursday, February 28, 2019
Pharma Reviews: Torrent Pharmaceuticals' India bet is yielding rich dividends
Acquisitions are loaded with risks, especially in the pharmaceuticals industry. But even with as many as five acquisitions in four years, Torrent ...
Read more: Torrent Pharmaceuticals' India bet is yielding rich dividends
Read more: Torrent Pharmaceuticals' India bet is yielding rich dividends
Pharma Reviews: Drug exporters wary of tension between India, Pakistan
The Indian pharmaceutical companies exports over USD 140 million to Pakistan with 50 per cent active pharmaceutical ingredients (API). "There are ...
Read more: Drug exporters wary of tension between India, Pakistan
Read more: Drug exporters wary of tension between India, Pakistan
Pharma Reviews: Minister interacts with diplomats of India-Latin America & Caribbean Strategic Economic Cooperation
Suresh Prabhu informed that owing to its competitive advantage in the sector, pharmaceutical products have also emerged as one of India's main ...
Read more: Minister interacts with diplomats of India-Latin America & Caribbean Strategic Economic Cooperation
Read more: Minister interacts with diplomats of India-Latin America & Caribbean Strategic Economic Cooperation
Wednesday, February 27, 2019
Pharma Reviews: India puts 42 non-scheduled cancer drugs under price control
The National Pharmaceutical Pricing Authority (NPPA) approved the formula which restricts the trade margin of the selling price by up to 30%.
Read more: India puts 42 non-scheduled cancer drugs under price control
Read more: India puts 42 non-scheduled cancer drugs under price control
Pharma Reviews: Govt to take measures on pharma sector issues: Minister
Govt to take measures on pharma sector issues: Minister ... Indian pharma industry plays a leading role globally, with 10% share of world production ...
Read more: Govt to take measures on pharma sector issues: Minister
Read more: Govt to take measures on pharma sector issues: Minister
Pharma Reviews: Drug exporters wary of tension between India, Pakistan
A senior executive of a city-based pharma company said as there was tension between both the nations, exports may become costlier to some of the ...
Read more: Drug exporters wary of tension between India, Pakistan
Read more: Drug exporters wary of tension between India, Pakistan
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. as prepared for oral testimony before the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations
FDA addresses the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. as prepared for oral testimony before the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. as prepared for oral testimony before the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations
Tuesday, February 26, 2019
Pharma Reviews: IAF strike across LoC is more effective than what Pakistan did in past decade: Afghan Journalist
The meeting was held to discuss the preparation of a strategy and an action plan which will help chemicals and pharma companies to boost exports ...
Read more: IAF strike across LoC is more effective than what Pakistan did in past decade: Afghan Journalist
Read more: IAF strike across LoC is more effective than what Pakistan did in past decade: Afghan Journalist
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on the agency’s 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse
FDA outlines 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on the agency’s 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on the agency’s 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse
US FDA News: FDA, CDC, and CMS launch task force to help facilitate rapid availability of diagnostic tests during public health emergencies
FDA, CDC, and CMS launch task force to help facilitate rapid availability of diagnostic tests during public health emergencies
Read more: FDA, CDC, and CMS launch task force to help facilitate rapid availability of diagnostic tests during public health emergencies
Read more: FDA, CDC, and CMS launch task force to help facilitate rapid availability of diagnostic tests during public health emergencies
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA’s modern approach to advanced pharmaceutical manufacturing
FDA issues information to industry on advanced pharmaceutical manufacturing
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA’s modern approach to advanced pharmaceutical manufacturing
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA’s modern approach to advanced pharmaceutical manufacturing
Pharma Reviews: IAF's strike across LoC is more effective than what Pakistan did in past decade: Afghan Journalist
After Indian Air Force devastated around 300 terrorists across LoC there is a ... Thank you @IAF_MCC and thank you India. ... Union Minister of Commerce and Industry, Suresh Prabhu, met representatives of pharma and chemicals ...
Read more: IAF's strike across LoC is more effective than what Pakistan did in past decade: Afghan Journalist
Read more: IAF's strike across LoC is more effective than what Pakistan did in past decade: Afghan Journalist
Pharma Reviews: Suresh Prabhu promises to up take issues for boosting exports in chemical sector
Indian pharma industry plays a leading role globally, with a 10% share of world production volumes and a 2.4% share globally in terms of value.
Read more: Suresh Prabhu promises to up take issues for boosting exports in chemical sector
Read more: Suresh Prabhu promises to up take issues for boosting exports in chemical sector
Pharma Reviews: 'TS govt will create 100-bn dollar pharma industry'
“We will realise the commitment of making Telangana the leader in research and innovation in pharma industry with initiatives like Pharma City, ...
Read more: 'TS govt will create 100-bn dollar pharma industry'
Read more: 'TS govt will create 100-bn dollar pharma industry'
Monday, February 25, 2019
US FDA News: Xeljanz, Xeljanz XR (tofacitinib): Safety Communication - Safety Trial Finds Increased Risk of Blood Clots in the Lungs and Death with Higher Dose in Rheumatoid Arthritis Patients
FDA is alerting the public that a safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR) was used in patients with rheumatoid arthritis (RA). FDA has not approved this 10 mg twice daily dose for RA; this dose is only approved in the dosing regimen for patients with ulcerative colitis
Read more: Xeljanz, Xeljanz XR (tofacitinib): Safety Communication - Safety Trial Finds Increased Risk of Blood Clots in the Lungs and Death with Higher Dose in Rheumatoid Arthritis Patients
Read more: Xeljanz, Xeljanz XR (tofacitinib): Safety Communication - Safety Trial Finds Increased Risk of Blood Clots in the Lungs and Death with Higher Dose in Rheumatoid Arthritis Patients
Pharma Reviews: VP Naidu's Paraguay visit: South American country offers big opportunities in space and pharma
Indian companies can find business opportunities in various sectors in South American nation Paraguay including organic fertilizers, pharmaceutical, ...
Read more: VP Naidu's Paraguay visit: South American country offers big opportunities in space and pharma
Read more: VP Naidu's Paraguay visit: South American country offers big opportunities in space and pharma
Pharma Reviews: History Maker : Murali Divi - Chairman & Managing Director of Divis Laboratories
Reportedly Murali is a well-known face in the pharma industry and is ... of the Indian pharmaceutical industry was seeking its fortune in challenging ...
Read more: History Maker : Murali Divi - Chairman & Managing Director of Divis Laboratories
Read more: History Maker : Murali Divi - Chairman & Managing Director of Divis Laboratories
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Frank Yiannas on a new strategy to advance FDA’s food safety mission and modernize oversight of imported food
American consumers expect a diverse, robust and fresh food supply that’s affordable and safe all year round. Since not all food products can be produced solely by domestic facilities, to help meet these demands, the U.S. imports about 15 percent of its overall food supply from more than 200 countries or territories representing about 125,000 international food facilities and farms. Over the past 15 years alone, we’ve seen a trend of rising imported foods. Other countries now supply about 32 percent of the fresh vegetables, 55 percent of the fresh fruit and 94 percent of the seafood that Americans enjoy.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Frank Yiannas on a new strategy to advance FDA’s food safety mission and modernize oversight of imported food
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Frank Yiannas on a new strategy to advance FDA’s food safety mission and modernize oversight of imported food
US FDA News: FDA issues warning letter to clinic illegally marketing unapproved thermography device, warns consumers to avoid using thermography devices to detect breast cancer
FDA issues warning letter to clinic illegally marketing unapproved thermography device, warns consumers to avoid using thermography devices to detect breast cancer
Read more: FDA issues warning letter to clinic illegally marketing unapproved thermography device, warns consumers to avoid using thermography devices to detect breast cancer
Read more: FDA issues warning letter to clinic illegally marketing unapproved thermography device, warns consumers to avoid using thermography devices to detect breast cancer
Pharma Reviews: History Maker : Murali Divi Chairman & Managing Director Divis Laboratories
Reportedly Murali is a well known face in pharma industry and is awarded several times for ... when most of the Indian pharmaceutical industry was seeking its fortune in challenging patents and selling generics in regulated markets.
Read more: History Maker : Murali Divi Chairman & Managing Director Divis Laboratories
Read more: History Maker : Murali Divi Chairman & Managing Director Divis Laboratories
Sunday, February 24, 2019
Pharma Reviews: In India, Apps Track Every Medicine You Take, And Your Data Is An 'Asset'
... tracks your medical prescriptions and stores your information forever, at a time when India has no laws governing what companies can and cannot ...
Read more: In India, Apps Track Every Medicine You Take, And Your Data Is An 'Asset'
Read more: In India, Apps Track Every Medicine You Take, And Your Data Is An 'Asset'
Pharma Reviews: 5 pharma stocks that show signs of growth and can be good bets
Most Indian pharma companies are trading at a discount to global peers in terms of valuations. Thirty four Indian pharma companies are tracked by ...
Read more: 5 pharma stocks that show signs of growth and can be good bets
Read more: 5 pharma stocks that show signs of growth and can be good bets
Saturday, February 23, 2019
Pharma Reviews: New drug panel could water down affordable healthcare
The sector is an essential part of initiatives like Make in India, which helps reduce our dependence on imports of bulk drugs and drug intermediaries.
Read more: New drug panel could water down affordable healthcare
Read more: New drug panel could water down affordable healthcare
Pharma Reviews: Dilip G Shah, the voice of domestic pharma industry, passes away at 77
Shah served as secretary general of the Indian Pharmaceutical Alliance and championed the cause of local drug makers on issues such as improved ...
Read more: Dilip G Shah, the voice of domestic pharma industry, passes away at 77
Read more: Dilip G Shah, the voice of domestic pharma industry, passes away at 77
Friday, February 22, 2019
Pharma Reviews: Indian generic industry loses a titan in DG Shah
Many in the Indian pharma industry saw Dilip Shah as the voice and resource that the generic pharma industry could always bank upon. Therefore, to ...
Read more: Indian generic industry loses a titan in DG Shah
Read more: Indian generic industry loses a titan in DG Shah
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to spur development of innovative devices, including new advancements in novel brain implants, that can help patients with paralysis or amputation gain mobility
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to spur development of innovative devices, including new advancements in novel brain implants, that can help patients with paralysis or amputation gain mobility
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to spur development of innovative devices, including new advancements in novel brain implants, that can help patients with paralysis or amputation gain mobility
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to spur development of innovative devices, including new advancements in novel brain implants, that can help patients with paralysis or amputation gain mobility
Pharma Reviews: Pharma veteran DG Shah passed away
Dilip G Shah (77), founder and Secretary-General of the Indian Pharmaceutical Alliance (IPA), a grouping of top Indian drug makers, passed away in ...
Read more: Pharma veteran DG Shah passed away
Read more: Pharma veteran DG Shah passed away
Pharma Reviews: IPA Founder DG Shah passes away
Dilip Girdharlal Shah, founder of the Indian Pharmaceutical Alliance (IPA), passed away in Mumbai recently. Shah served as the Chief Executive ...
Read more: IPA Founder DG Shah passes away
Read more: IPA Founder DG Shah passes away
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on the FDA’s continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad
FDA outlines continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on the FDA’s continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on the FDA’s continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad
Pharma Reviews: Pharma Major AstraZeneca and NASSCOM tie-up to Launch Accelerator for Healthcare Startups
Global biopharmaceutical major AstraZeneca and Indian IT industry body Nasscom have joined hands to set up an accelerator programme to support ...
Read more: Pharma Major AstraZeneca and NASSCOM tie-up to Launch Accelerator for Healthcare Startups
Read more: Pharma Major AstraZeneca and NASSCOM tie-up to Launch Accelerator for Healthcare Startups
Pharma Reviews: DG Shah founder of Indian Pharmaceutical Alliance dies at age 77
Dilip Shah, founder of the Indian Pharmaceutical Alliance (IPA) the organisation that represented the interests of Indian drug makers passed away in ...
Read more: DG Shah founder of Indian Pharmaceutical Alliance dies at age 77
Read more: DG Shah founder of Indian Pharmaceutical Alliance dies at age 77
Thursday, February 21, 2019
Pharma Reviews: 4th International Conference on Pharma & Medical Devices concludes
Knowledge sessions were focused on promoting an innovative ecosystem in India for the pharmaceutical industry, interaction with State Drug ...
Read more: 4th International Conference on Pharma & Medical Devices concludes
Read more: 4th International Conference on Pharma & Medical Devices concludes
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes
FDA releases the second of two draft guidances aimed at supporting the development of novel nicotine replacement therapies.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on additional steps by the agency to support the development of safe and effective novel nicotine replacement therapies to help smokers quit cigarettes
US FDA News: FDA advances new proposed regulation to make sure that sunscreens are safe and effective
FDA issues a proposed rule that would update regulatory requirements for most sunscreen products in the United States
Read more: FDA advances new proposed regulation to make sure that sunscreens are safe and effective
Read more: FDA advances new proposed regulation to make sure that sunscreens are safe and effective
Pharma Reviews: Indian IT and Pharma Industry May Get Access To China as Delhi Looks To Reduce Trade Deficit
India asked for more actions from the Chinese side to support and promote Indian goods in China. Indian and Chinese officials from Commerce ...
Read more: Indian IT and Pharma Industry May Get Access To China as Delhi Looks To Reduce Trade Deficit
Read more: Indian IT and Pharma Industry May Get Access To China as Delhi Looks To Reduce Trade Deficit
Pharma Reviews: Below the radar thus far, pharma picking up pace, slowly but surely
The domestic pharma industry can be divided into three categories. .... structurally outperform, led by recovery in Indian pharma market, a relatively ...
Read more: Below the radar thus far, pharma picking up pace, slowly but surely
Read more: Below the radar thus far, pharma picking up pace, slowly but surely
Wednesday, February 20, 2019
Pharma Reviews: Unexciting Q3 results of pharma companies give cues about the US market
The December quarter (Q3) results of Indian pharmaceutical companies, while unexciting, gave important cues about the US market. One, companies ...
Read more: Unexciting Q3 results of pharma companies give cues about the US market
Read more: Unexciting Q3 results of pharma companies give cues about the US market
Pharma Reviews: After giant pharma push, China keeps Indian drug makers waiting
It included senior officials from the commerce ministry and 27 Indian pharma companies, including Cipla, Natco Pharma, Lupin and Sun Pharma.
Read more: After giant pharma push, China keeps Indian drug makers waiting
Read more: After giant pharma push, China keeps Indian drug makers waiting
Tuesday, February 19, 2019
Product Recall Alerts: RECALL ALERT: Baby gripe water sold at Dollar General recalled
Kingston Pharma has received one report of a week-old infant having difficulty swallowing the product and three complaints attributed to the ...
Read more: RECALL ALERT: Baby gripe water sold at Dollar General recalled
Read more: RECALL ALERT: Baby gripe water sold at Dollar General recalled
Pharma Reviews: To cut import, govt to boost production of drug ingredient
At present, India gets around 70% of its API supplies from China. ... According to industry executives, the landed price of API from China is 15-20% ...
Read more: To cut import, govt to boost production of drug ingredient
Read more: To cut import, govt to boost production of drug ingredient
Pharma Reviews: BQuick On Feb. 19: Top 10 Stories In Under 10 Minutes
India eased angel tax norms in a big relief for startups that feared tax demands ... The developments led global pharma companies to look to diversify ...
Read more: BQuick On Feb. 19: Top 10 Stories In Under 10 Minutes
Read more: BQuick On Feb. 19: Top 10 Stories In Under 10 Minutes
Pharma Reviews: Call for separate regulations for medical devices and OTC drugs
Knowledge sessions were focused towards promoting innovative ecosystem in India for pharmaceutical industry, interaction with State Drug ...
Read more: Call for separate regulations for medical devices and OTC drugs
Read more: Call for separate regulations for medical devices and OTC drugs
Pharma Reviews: Ailing With Uncertainty
Speaking to Business Today, DG Shah, Secretary General of the Indian Pharmaceutical Alliance - which has leading Indin pharmaceutical companies ...
Read more: Ailing With Uncertainty
Read more: Ailing With Uncertainty
Pharma Reviews: Injectable units under cloud as India lacks experts in aseptic practices: Amit Rajan, Prosfora Tech
More than 80% of the Indian pharma companies who are into sterile manufacturing like injectables, have been approved by the US FDA on a VAI ...
Read more: Injectable units under cloud as India lacks experts in aseptic practices: Amit Rajan, Prosfora Tech
Read more: Injectable units under cloud as India lacks experts in aseptic practices: Amit Rajan, Prosfora Tech
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions
FDA statement cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions
Product Recall Alerts: RECALL ALERT: Baby gripe water recalled for 'undissolved ingredient'
To date, Kingston Pharma LLC has received one report of a one-week old infant having difficulty when swallowing the product and three complaints ...
Read more: RECALL ALERT: Baby gripe water recalled for 'undissolved ingredient'
Read more: RECALL ALERT: Baby gripe water recalled for 'undissolved ingredient'
Pharma Reviews: Doctors in Kashmir plan to boycott Macleods, Intas Pharma
Last week, Macleods Pharmaceuticals, one of the top five Indian drug companies, had said it was suspending its executive Riyaz Ahmed Wani for ...
Read more: Doctors in Kashmir plan to boycott Macleods, Intas Pharma
Read more: Doctors in Kashmir plan to boycott Macleods, Intas Pharma
Monday, February 18, 2019
Pharma Reviews: A Breed Of Pharma Companies Is Doing Well. Here's Why
As generic drugmakers face pricing pressure in the U.S. because of increasing competition from China, a crackdown on polluting industries by India's ...
Read more: A Breed Of Pharma Companies Is Doing Well. Here's Why
Read more: A Breed Of Pharma Companies Is Doing Well. Here's Why
Pharma Reviews: Argentina seeks Indian investments to boost economic cooperation
Speaking at the forum, Commerce and Industry Minister Suresh Prabhu ... in this," he said adding India has huge expertise in IT and pharma sectors.
Read more: Argentina seeks Indian investments to boost economic cooperation
Read more: Argentina seeks Indian investments to boost economic cooperation
Pharma Reviews: Indian pharma players need to explore new regions for exports
Indian pharma industry, worth $34 billion in 2018, has exhibited huge potential and is expected to grow at a compound annual growth rate (CAGR) of ...
Read more: Indian pharma players need to explore new regions for exports
Read more: Indian pharma players need to explore new regions for exports
Pharma Reviews: Affordable, accessible healthcare, a government priority: DV Sadananda Gowda
The 4th International Conference on Pharmaceutical & Medical Device ... the industry believed in universal healthcare at affordable price for all Indian ...
Read more: Affordable, accessible healthcare, a government priority: DV Sadananda Gowda
Read more: Affordable, accessible healthcare, a government priority: DV Sadananda Gowda
Pharma Reviews: Pharma industry to grow at CAGR of 15 percent: Minister
Pharma industry to grow at CAGR of 15 percent: Minister ... and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry (FICCI).
Read more: Pharma industry to grow at CAGR of 15 percent: Minister
Read more: Pharma industry to grow at CAGR of 15 percent: Minister
Pharma Reviews: Access to affordable medical care and National Health Protection Scheme
Mr S Sridhar, Chairman, FICCI Pharma Committee said that industry believed in universal healthcare at affordable price for all Indian citizens, adding ...
Read more: Access to affordable medical care and National Health Protection Scheme
Read more: Access to affordable medical care and National Health Protection Scheme
Pharma Reviews: Synthetic fibres contribute to plastic pollution in environment: Study
“While India continues to maintain leadership position in manufacturing and supply of high-quality generic medicines, the Government's focus is on ...
Read more: Synthetic fibres contribute to plastic pollution in environment: Study
Read more: Synthetic fibres contribute to plastic pollution in environment: Study
Pharma Reviews: Pharma industry to grow at CAGR of 15% in future: Minister Gowda at India Pharma 2019
"While India continues to maintain leadership position in manufacturing and supply of high-quality generic medicines, the Government's focus is on ...
Read more: Pharma industry to grow at CAGR of 15% in future: Minister Gowda at India Pharma 2019
Read more: Pharma industry to grow at CAGR of 15% in future: Minister Gowda at India Pharma 2019
Pharma Reviews: Fertilizers Minister seeks active participation of pharma sector in Ayushman Bharat
The pharmaceutical industry in India was valued at over USD 34 billion in 2017-18 with almost 50:50 share of domestic and export markets, he said ...
Read more: Fertilizers Minister seeks active participation of pharma sector in Ayushman Bharat
Read more: Fertilizers Minister seeks active participation of pharma sector in Ayushman Bharat
Pharma Reviews: Indian Oil Signs deal worth USD 1.5 billion to import more than 3 million tonne crude oil
In the first-ever deal by an Indian company, Indian Oil Corp (IOC) Monday ... position in manufacturing and supply of high quality generic medicines".
Read more: Indian Oil Signs deal worth USD 1.5 billion to import more than 3 million tonne crude oil
Read more: Indian Oil Signs deal worth USD 1.5 billion to import more than 3 million tonne crude oil
Sunday, February 17, 2019
Pharma Reviews: Indian Inc's Q3 results: Few companies pulled down earnings growth
Indian Inc's Q3 results: Few companies pulled down earnings growth .... Drugs Administration-related issues continue to plague the pharma industry.
Read more: Indian Inc's Q3 results: Few companies pulled down earnings growth
Read more: Indian Inc's Q3 results: Few companies pulled down earnings growth
Pharma Reviews: Promote pharmacy education: PCI chief B. Suresh laid
Taking part in the inauguration of the two-day Indian Pharmaceutical Association-Students' Forum, Dr B. Suresh urged students who are pursuing ...
Read more: Promote pharmacy education: PCI chief B. Suresh laid
Read more: Promote pharmacy education: PCI chief B. Suresh laid
Saturday, February 16, 2019
Pharma Reviews: Zydus Cadila and Macleods Pharma suspend Kashmiri employees, issue show-cause notices
One of India's largest drugmaker Zydus Cadila and smaller firm Macleods Pharma suspended their Srinagar-based company executives for posting ...
Read more: Zydus Cadila and Macleods Pharma suspend Kashmiri employees, issue show-cause notices
Read more: Zydus Cadila and Macleods Pharma suspend Kashmiri employees, issue show-cause notices
Friday, February 15, 2019
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition
FDA announces new draft guidance titled, Competitive Generic Therapies, to help provide even greater clarity to industry about the CGT pathway.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition
Pharma Reviews: Share market update: Nifty Pharma index dips; Dr. Reddy's Lab plunges 9%
Shares of YES Bank, ONGC, Ashok Leyland, ITC, SBI, Vodafone Idea, ICICI Bank, Vedanta, Indian Oil Corp and Tata Motors were among the most ...
Read more: Share market update: Nifty Pharma index dips; Dr. Reddy's Lab plunges 9%
Read more: Share market update: Nifty Pharma index dips; Dr. Reddy's Lab plunges 9%
Thursday, February 14, 2019
US FDA News: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
Read more: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
Read more: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
US FDA News: FDA issues warning letter to doctor for illegally marketing unapproved device with claims to prevent and treat tightening of scar tissue around breast implants
FDA issues warning letter to doctor for illegally marketing unapproved device with claims to prevent and treat tightening of scar tissue around breast implants
Read more: FDA issues warning letter to doctor for illegally marketing unapproved device with claims to prevent and treat tightening of scar tissue around breast implants
Read more: FDA issues warning letter to doctor for illegally marketing unapproved device with claims to prevent and treat tightening of scar tissue around breast implants
Pharma Reviews: Sun Pharma just made more profits than expected. Can bruised investors say hallelujah?
On Tuesday, India's largest drug maker by market value posted a four-fold jump in its third-quarter net profit to INR1,242 crore from INR322 crore in the ...
Read more: Sun Pharma just made more profits than expected. Can bruised investors say hallelujah?
Read more: Sun Pharma just made more profits than expected. Can bruised investors say hallelujah?
Wednesday, February 13, 2019
Product Recall Alerts: Additional blood pressure and heart medication recalled from pharmacies
More information [here].(http://bit.ly/2DD57A3medication-recalled-from-pharmacies-by-mhra).
Read more: Additional blood pressure and heart medication recalled from pharmacies
Read more: Additional blood pressure and heart medication recalled from pharmacies
Pharma Reviews: Market Live: Nifty below 10800, Sensex falls 150 pts; Adani Ports gains 4%
Market Live: Nifty below 10,800, Sensex falls 150 pts; Adani Ports gains 4% .... Sun Pharma, India's largest drug maker on February 12 said it it had ...
Read more: Market Live: Nifty below 10800, Sensex falls 150 pts; Adani Ports gains 4%
Read more: Market Live: Nifty below 10800, Sensex falls 150 pts; Adani Ports gains 4%
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Frank Yiannas on findings from the agency’s investigation of the November 2018 outbreak of E. coli O157:H7 in California-linked romaine lettuce
Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Frank Yiannas on findings from the agency’s investigation of the November 2018 outbreak of E. coli O157:H7 in California-linked romaine lettuce
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Frank Yiannas on findings from the agency’s investigation of the November 2018 outbreak of E. coli O157:H7 in California-linked romaine lettuce
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Frank Yiannas on findings from the agency’s investigation of the November 2018 outbreak of E. coli O157:H7 in California-linked romaine lettuce
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on new programs to promote the adoption of innovations in drug manufacturing that can improve quality and lower drug costs
FDA announces programs to promote adoption of innovations in drug manufacturing
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on new programs to promote the adoption of innovations in drug manufacturing that can improve quality and lower drug costs
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on new programs to promote the adoption of innovations in drug manufacturing that can improve quality and lower drug costs
Pharma Reviews: Market Live: Indices turn red with Nifty below 10850, Sensex flat; oil & gas stocks fall
Market Live: Indices turn red with Nifty below 10,850, Sensex flat; oil & gas .... Sun Pharma, India's largest drug maker on February 12 said it it had ...
Read more: Market Live: Indices turn red with Nifty below 10850, Sensex flat; oil & gas stocks fall
Read more: Market Live: Indices turn red with Nifty below 10850, Sensex flat; oil & gas stocks fall
Tuesday, February 12, 2019
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic
FDA issues first warning letter under Drug Supply Chain Security Act to McKesson Corp. for violations highlighted by a concerning tampering incident.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic
Pharma Reviews: Stocks To Watch: Axis Bank, Coal India, Dr. Reddy's, Hindalco, SBI, Sun Pharma
Axis Bank: Specified Undertaking of Unit Trust of India (SUUTI) plans to sell 1.98 percent stake ... Coal India; Hindalco Industries; Sun Pharmaceutical ...
Read more: Stocks To Watch: Axis Bank, Coal India, Dr. Reddy's, Hindalco, SBI, Sun Pharma
Read more: Stocks To Watch: Axis Bank, Coal India, Dr. Reddy's, Hindalco, SBI, Sun Pharma
Monday, February 11, 2019
Pharma Reviews: Live: Nifty Futures Suggests Weak Start; Axis Bank, Coal India, Sun Pharma In Focus
Ajanta Pharma record-date for share buyback. Religare Enterprises, Vipul, Binani Industries, Reliance Home Finance, Reliance Naval & Engineering, ...
Read more: Live: Nifty Futures Suggests Weak Start; Axis Bank, Coal India, Sun Pharma In Focus
Read more: Live: Nifty Futures Suggests Weak Start; Axis Bank, Coal India, Sun Pharma In Focus
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new data demonstrating rising youth use of tobacco products and the agency’s ongoing actions to confront the epidemic of youth e-cigarette use
Statement from FDA Commissioner Scott Gottlieb, M.D., on new data demonstrating rising youth use of tobacco products and the agency’s ongoing actions to confront the epidemic of youth e-cigarette use.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new data demonstrating rising youth use of tobacco products and the agency’s ongoing actions to confront the epidemic of youth e-cigarette use
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new data demonstrating rising youth use of tobacco products and the agency’s ongoing actions to confront the epidemic of youth e-cigarette use
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight
FDA announces new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight
US FDA News: FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer’s disease
FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer’s disease
Read more: FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer’s disease
Read more: FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer’s disease
Pharma Reviews: Indian pharma lobby seeks removal of India from US patent violator list
The Indian Pharmaceutical Alliance (IPA), the lobby group for the domestic pharma industry, has filed a submission to the US Trade Representative ...
Read more: Indian pharma lobby seeks removal of India from US patent violator list
Read more: Indian pharma lobby seeks removal of India from US patent violator list
Sunday, February 10, 2019
Pharma Reviews: Geistlich has always been known for being very serious about the science we do : Dr Matthias P ...
Geistlich Pharma India, Indian Market ... have a similar situation would be Brazil but India being at least in the dental industry, in the developing stage.
Read more: Geistlich has always been known for being very serious about the science we do : Dr Matthias P ...
Read more: Geistlich has always been known for being very serious about the science we do : Dr Matthias P ...
Saturday, February 9, 2019
Pharma Reviews: Pharma weekly wrap: Government to regulate medical devices along the lines of drugs
Medical devices are quite different from pharmaceutical products with a lot of ... “The majority of medical devices are completely unregulated in India.
Read more: Pharma weekly wrap: Government to regulate medical devices along the lines of drugs
Read more: Pharma weekly wrap: Government to regulate medical devices along the lines of drugs
Friday, February 8, 2019
Pharma Reviews: Final frontier: Why India's booming Pharma companies are finding it tough to get into Argentinean ...
India is among the top 6th global Pharmaceutical producers in the world. However, for the past 30 years Indian pharmaceutical products had very ...
Read more: Final frontier: Why India's booming Pharma companies are finding it tough to get into Argentinean ...
Read more: Final frontier: Why India's booming Pharma companies are finding it tough to get into Argentinean ...
Thursday, February 7, 2019
US FDA News: FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
FDA announces pilot program to improve ability to trace prescription drugs at all points in the drug distribution chain.
Read more: FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
Read more: FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
US FDA News: FDA pursues order barring specific retailers from selling tobacco products as part of its continuing efforts to target youth tobacco use
FDA has initiated enforcement action against certain retail locations of Walgreen Co. and Circle K Stores Inc. for repeated violations of restrictions on the sale and distribution of tobacco products, including sales of cigars and menthol cigarettes to minors.
Read more: FDA pursues order barring specific retailers from selling tobacco products as part of its continuing efforts to target youth tobacco use
Read more: FDA pursues order barring specific retailers from selling tobacco products as part of its continuing efforts to target youth tobacco use
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls
Product Recall Alerts: Health Alert: Infants' Ibuprofen Recalled Due to High Concentrations
The recalled products have been found to potentially have higher ... that infants, who may be more susceptible to a higher potency level of drug, and ...
Read more: Health Alert: Infants' Ibuprofen Recalled Due to High Concentrations
Read more: Health Alert: Infants' Ibuprofen Recalled Due to High Concentrations
Wednesday, February 6, 2019
US FDA News: Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
Read more: Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
Read more: Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
Pharma Reviews: 'Integrated approach needed to bring in universal healthcare'
MUMBAI: India needs a comprehensive approach to healthcare, where the ... Indian Pharmaceutical Alliance, said at CII Healthcare, Pharma and ...
Read more: 'Integrated approach needed to bring in universal healthcare'
Read more: 'Integrated approach needed to bring in universal healthcare'
US FDA News: Federal court enters consent decree against Ranier’s Rx Laboratory and owner for manufacturing purportedly sterile drug products in insanitary conditions
Federal court enters consent decree against Ranier’s Rx Laboratory and owner for manufacturing purportedly sterile drug products in insanitary conditions
Read more: Federal court enters consent decree against Ranier’s Rx Laboratory and owner for manufacturing purportedly sterile drug products in insanitary conditions
Read more: Federal court enters consent decree against Ranier’s Rx Laboratory and owner for manufacturing purportedly sterile drug products in insanitary conditions
US FDA News: FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
FDA approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.
Read more: FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
Read more: FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
Tuesday, February 5, 2019
Pharma Reviews: Sugar stocks to do well for next 2-3 quarters: Dipan Mehta
Given the pharmaceutical industry scenario, we have been generally very underweight in the entire pharma pack be it Lupin, Sun Pharma or Cipla, ...
Read more: Sugar stocks to do well for next 2-3 quarters: Dipan Mehta
Read more: Sugar stocks to do well for next 2-3 quarters: Dipan Mehta
Sunday, February 3, 2019
Pharma Reviews: Should India be worried about Brexit?
The pharma sector is another area where Indian businesses have a lot of exposure to the UK. Brexit is obviously bad news for them. Their revenues ...
Read more: Should India be worried about Brexit?
Read more: Should India be worried about Brexit?
Friday, February 1, 2019
Pharma Reviews: Compulsory Licensing of Pharmaceutical Patents in India
The trend of continued rejection of compulsory licence applications in India goes against the local generic drug manufacturers and public health ...
Read more: Compulsory Licensing of Pharmaceutical Patents in India
Read more: Compulsory Licensing of Pharmaceutical Patents in India
Pharma Reviews: India is going to be the pharmacy capital of the world by 2020
Hyderabad: "One revolutionary drug can change the landscape of India pharma industry and also the world”, said Pharmacy Council of India ...
Read more: India is going to be the pharmacy capital of the world by 2020
Read more: India is going to be the pharmacy capital of the world by 2020
US FDA News: FDA warns patients and doctors about recall of home-use test strips used with device to monitor blood thinner warfarin, not authorized for sale in U.S.
Medical product distributor issued voluntary recall of certain Roche Diagnostics test strips used with CoaguChek test meter devices.
Read more: FDA warns patients and doctors about recall of home-use test strips used with device to monitor blood thinner warfarin, not authorized for sale in U.S.
Read more: FDA warns patients and doctors about recall of home-use test strips used with device to monitor blood thinner warfarin, not authorized for sale in U.S.
Subscribe to:
Comments (Atom)